Flex has recently expanded its digital health capabilities through a partnership with Google Cloud Platform — launching its BrightInsight managed service that delivers real-time information about connected drug, device or combination products.
BrightInsight is a secure, managed services solutions that runs on the Google Cloud Platform to gather data, according to Flex.
“We saw the need for a secure cloud platform designed to support highly-regulated connected drug delivery and medical devices, going beyond simple connectivity to deliver real-time intelligence and actionable insights,” Kal Patel, senior VP of digital health at Flex, said in a press release. “With our 20 years of experience operating in global regulated medical environments, and having deployed more than 75 regulated hardware and software medical products, Flex can combine our cross-industry capabilities to simplify our customers’ digital transformation.”
Flex (San Jose, Calif.) and Google Cloud are partnering to deliver customizable analytics dashboards created by Google Cloud’s machine learning and artificial intelligence. The collaboration also allows BrightInsight to store its data securely while analyzing and gaining insights from health information without pharmaceutical and medical technology patients having to manage other infrastructure.
Flex touts that BrightInsight can be used in a variety of applications including controlling connected devices, drug dosing, decision support, personalized patient interventions, trend analysis and artificial intelligence-driven insights.
“Google Cloud is committed to leveraging our deep engineering expertise to accelerate innovation in digital healthcare,” Gregory Moore, VP of healthcare at Google Cloud, said. “With a partner like Flex, we will enable our customers to develop innovative solutions and leverage machine learning-based analytics that can turn new data sets from wearables, medical devices, therapies and apps into actionable information for patients and providers.”
BrightInsight is currently designed to work with CE-marked and FDA-regulated Class I, II and III medical devices, combination products and software as a medical device requirements. It also features a modular platform architecture to support its customization and for global implementation.
Flex also suggests that BrightInsight reduces the regulatory bottlenecks that cause costly delays by featuring regulatory design control and file management of master files with the FDA.
BrightInSight is built as part of a quality management system that is ISO 13485 and HIPAA compliant. The company is currently working toward HITRUST certification.
Tell Us What You Think!